Imigenebio, Inc. Changes Name from Ikena Oncology, Inc.
Ticker: IMA · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1835579
| Field | Detail |
|---|---|
| Company | Ikena Oncology, INC. (IMA) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: name-change, corporate-action
TL;DR
IKNA is now IMGB. Name change filed 7/25.
AI Summary
On July 25, 2025, Imigenebio, Inc. (formerly Ikena Oncology, Inc.) filed an 8-K report. The company, incorporated in Delaware, is located at 12526 High Bluff Drive, Suite 345, San Diego, California, 92130. Its former name was Ikena Oncology, Inc., with a previous address at 645 Summer Street, Suite 101, Boston, Massachusetts.
Why It Matters
This filing indicates a significant corporate identity change, which could signal strategic shifts or rebranding efforts by the company.
Risk Assessment
Risk Level: low — This filing is a routine corporate name change announcement and does not involve financial performance or operational changes.
Key Players & Entities
- Imigenebio, Inc. (company) — Current registrant name
- Ikena Oncology, Inc. (company) — Former registrant name
- July 25, 2025 (date) — Date of report
- 12526 High Bluff Drive, Suite 345, San Diego, California, 92130 (address) — Principal executive offices
- 645 Summer Street, Suite 101, Boston, Massachusetts (address) — Former address
FAQ
What is the new name of the company?
The new name of the company is Imigenebio, Inc.
What was the company's former name?
The company's former name was Ikena Oncology, Inc.
On what date was this report filed?
This report was filed on July 25, 2025.
Where are the company's principal executive offices located?
The company's principal executive offices are located at 12526 High Bluff Drive, Suite 345, San Diego, California, 92130.
What was the company's previous address?
The company's previous address was 645 Summer Street, Suite 101, Boston, Massachusetts.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding Ikena Oncology, Inc. (IMA).